Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,24 € ↓ -0,74 (-1,16%)
2026-06-05
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionBnp Paribas Arbitrage, Sa
Latest Disclosed Ownership139,257 shares
Latest Disclosed Value $ 5,613,450
Bnp Paribas Arbitrage, Sa reports 404.08% increase in ownership of HTD / Corcept Therapeutics Incorporated

On May 12, 2026 - Bnp Paribas Arbitrage, Sa filed a 13F-HR form disclosing ownership of 139,257 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $4,802,974 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 27,626 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 404.08% during the quarter. The current value of the position is $8,806,613 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F Corcept Therapeutics Equity 218352102 139,257 111,631 404.08 5,613 484.08 0.0003
2026-02-10 2025-12-31 13F Corcept Therapeutics Equity 218352102 27,626 -4,403 -13.75 961 -63.89 0.0004
2025-11-13 2025-09-30 13F Corcept Therapeutics Equity 218352102 32,029 4,253 15.31 2,662 30.57 0.0014
2025-08-14 2025-06-30 13F Corcept Therapeutics Equity 218352102 27,776 -45,785 -62.24 2,039 -75.74 0.0012
2025-05-14 2025-03-31 13F Corcept Therapeutics Equity 218352102 73,561 15,731 27.20 8,402 188.33 0.0049
2025-02-14 2024-12-31 13F Corcept Therapeutics Equity 218352102 57,830 -42,258 -42.22 2,914 -37.09 0.0016
2024-11-13 2024-09-30 13F Corcept Therapeutics Equity 218352102 100,088 -87,846 -46.74 4,632 -24.13 0.0031
2024-08-13 2024-06-30 13F Corcept Therapeutics Equity 218352102 187,934 -23,658 -11.18 6,106 14.54 0.0050
2024-05-01 2024-03-31 13F Corcept Therapeutics Equity 218352102 211,592 140,815 198.96 5,330 131.94 0.0047
2024-02-14 2023-12-31 13F/A-2 Corcept Therapeutics Equity 218352102 70,777 -20,768 -22.69 2,299 -7.86 0.0026
2024-02-07 2023-12-31 13F/A-1 Corcept Therapeutics Equity 218352102 70,777 -20,768 2,299 0.0003
2024-02-07 2023-12-31 13F Corcept Therapeutics Equity 218352102 70,777 2,299
2023-11-14 2023-09-30 13F Corcept Therapeutics Equity 218352102 91,545 69,905 323.04 2,494 418.50 0.0032
2023-08-09 2023-06-30 13F Corcept Therapeutics Equity 218352102 21,640 -34,678 -61.58 481 -60.54 0.0006
2023-05-12 2023-03-31 13F CORCEPT THERAPEUTICS EQUITY 218352102 56,318 37,859 205.10 1,220 225.94 0.0017
2023-02-14 2022-12-31 13F Corcept Therapeutics Equity 218352102 18,459 -25,398 -57.91 375 -66.73 0.0006
2022-11-16 2022-09-30 13F/A-1 Corcept Therapeutics Equity 218352102 43,857 19,187 77.77 1,124 91.81 0.0018
2022-11-15 2022-09-30 13F Corcept Therapeutics Equity 218352102 43,857 19,187 1,124 0.0003
2022-08-12 2022-06-30 13F Corcept Therapeutics Equity 218352102 24,670 -10,198 -29.25 587 -25.35 0.0009
2022-05-18 2022-03-31 13F/A-1 Corcept Therapeutics Equity 218352102 34,868 -5,200 -12.98 785 -1.01 0.0011
2022-02-09 2021-12-31 13F CORCEPT THERAPEUTICS EQUITY 218352102 40,068 -58,957 -59.54 793 -59.29 0.0011
2021-11-16 2021-09-30 13F/A-1 CORCEPT THERAPEUTICS EQUITY 218352102 99,025 57,737 139.84 1,949 114.54 0.0028
2021-11-12 2021-09-30 13F CORCEPT THERAPEUTICS EQUITY 218352102 34,650 -6,638 603 0.0000
2021-08-10 2021-06-30 13F CORCEPT THERAPEUTICS EQUITY 218352102 41,288 9,286 29.02 908 19.32 0.0012
2021-05-07 2021-03-31 13F CORCEPT THERAPEUTICS EQUITY 218352102 32,002 -652 -2.00 761 -10.89 0.0011
2021-02-10 2020-12-31 13F CORCEPT THERAPEUTICS EQUITY 218352102 32,654 -1,996 -5.76 854 41.63 0.0016
2020-10-30 2020-09-30 13F CORCEPT THERAPEUTICS EQUITY 218352102 34,650 18,323 112.23 603 120.07 0.0009
2020-08-06 2020-06-30 13F CORCEPT THERAPEUTICS EQUITY 218352102 16,327 -41,638 -71.83 275 -60.23 0.0005
2020-05-13 2020-03-31 13F CORCEPT THERAPEUTICS EQUITY 218352102 57,965 32,803 130.37 689 126.64 0.0014
2020-02-12 2019-12-31 13F CORCEPT THERAPEUTICS EQUITY 218352102 25,162 7,533 42.73 304 22.09 0.0006
2019-11-07 2019-09-30 13F CORCEPT THERAPEUTICS EQUITY 218352102 17,629 -31,187 -63.89 249 -54.23 0.0004
2019-07-30 2019-06-30 13F CORCEPT THERAPEUTICS EQUITY 218352102 48,816 26,265 116.47 544 106.06 0.0011
2019-04-25 2019-03-31 13F CORCEPT THERAPEUTICS EQUITY 218352102 22,551 20,297 900.49 265 780.00 0.0006
2019-02-12 2018-12-31 13F CORCEPT THERAPEUTICS EQUITY 218352102 2,254 -3,207 -58.73 30 -60.53 0.0001
2018-11-07 2018-09-30 13F CORCEPT THERAPEUTICS EQUITY 218352102 5,461 492 9.90 77 -2.56 0.0001
2018-07-25 2018-06-30 13F CORCEPT THERAPEUTICS EQUITY 218352102 4,969 -25,154 -83.50 78 -84.24 0.0001
2018-05-11 2018-03-31 13F CORCEPT THERAPEUTICS EQUITY 218352102 30,123 -8,461 -21.93 496 -28.88 0.0009
2018-03-05 2017-12-31 13F/A-1 CORCEPT THERAPEUTICS EQUITY 218352102 38,584 29,420 321.04 697 295.45 0.0012
2018-02-01 2017-12-31 13F CORCEPT THERAPEUTICS EQUITY 218352102 38,584 29,420 697
2017-11-03 2017-09-30 13F CORCEPT THERAPEUTICS STOCK 218352102 9,164 -543 -5.59 177 54.39 0.0004
2017-08-03 2017-06-30 13F CORCEPT THERAPEUTICS STOCK 218352102 9,707 9,388 2,942.95 115 3,700.00 0.0003
2017-05-03 2017-03-31 13F CORCEPT THERAPEUTICS STOCK 218352102 319 -834 -72.33 3 -62.50 0.0000
2017-02-14 2016-12-31 13F CORCEPT THERAPEUTICS STOCK 218352102 1,153 -3,897 -77.17 8 -75.00 0.0000
2016-10-05 2016-09-30 13F * CORCEPT THERAPEUTICS INC COM STOCK 218352102 5,050 2,147 73.96 33 113.33 0.0001
2016-07-06 2016-06-30 13F * CORCEPT THERAPEUTICS INC COM STOCK 218352102 2,903 2,903 0.00 16 0.0001
2016-04-22 2016-03-31 13F * CORCEPT THERAPEUTICS INC COM STOCK 218352102 0 -5,740 -100.00 0 -100.00
2016-04-19 2015-12-31 13F/A-1 * CORCEPT THERAPEUTICS INC COM STOCK 218352102 5,740 -6,791 -54.19 29 -40.43 0.0001
2016-02-10 2015-12-31 13F * CORCEPT THERAPEUTICS INC COM STOCK 218352102 5,740 29
2015-11-13 2015-09-30 13F * CORCEPT THERAPEUTICS INC COM STOCK 218352102 12,531 7,382 143.37 47 56.67 0.0001
2015-08-14 2015-06-30 13F CORCEPT THERAPEUTICS INC COM STOCK 218352102 5,149 3,896 310.93 31 328.57 0.0001
2015-05-15 2015-03-31 13F * CORCEPT THERAPEUTICS INC COM STOCK 218352102 1,253 1,253 0.00 7 0.0000
2015-02-11 2014-12-31 13F * CORCEPT THERAPEUTICS INC COM STOCK 218352102 0 -3,112 -100.00 0 -100.00
2014-11-12 2014-09-30 13F * CORCEPT THERAPEUTICS INC COM STOCK 218352102 3,112 2,738 732.09 8 700.00 0.0000
2014-08-14 2014-06-30 13F/A-1 * CORCEPT THERAPEUTICS INC COM STOCK 218352102 374 -315 -45.72 1 -50.00 0.0000
2014-08-14 2014-06-30 13F CORCEPT THERAPEUTICS INC COM STOCK 218352102 374 1
2014-04-02 2013-12-31 13F/A-1 CORCEPT THERAPEUTICS STOCK 218352102 689 -14,166 -95.36 2 -91.30 0.0000
2013-11-13 2013-09-30 13F CORCEPT THERAPEUTICS STOCK 218352102 14,855 -8,534 -36.49 24 -42.50 0.0000
2013-08-13 2013-06-30 13F CORCEPT THERAPEUTICS STOCK 218352102 23,389 23,389 40 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.